Invesco Ltd. Atreca, Inc. Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.87 - $6.29 $34,749 - $76,159	-12,108 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.91 - $9.07 $5,567 - $10,285	1,134 Added 10.33%	12,108 $76,000
Q2 2021 Aug 17, 2021	BUY	$7.82 - $13.8 $85,816 - $151,441	10,974 New	10,974 $94,000
Q3 2020 Nov 16, 2020	SELL	$12.67 - $23.19 $419,769 - $768,307	-33,131 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$12.52 - $23.45 $36,495 - $68,356	-2,915 Reduced 8.09%	33,131 $705,000
Q1 2020 May 15, 2020	BUY	$11.4 - $27.28 $410,924 - $983,334	36,046 New	36,046 $597,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.